The FDA is expected to decide on treatments for breast cancer, EBV+ post-transplant lymphoproliferative disease, focal segmental glomerulosclerosis, presbyopia, and severe allergic reactions.
Ultrasound can provide relevant information to support the diagnosis of vascular adverse events (VAEs) associated with use of cosmetic fillers, including hyaluronic acid (HA).
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback